| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8658842 | Diabetes & Metabolic Syndrome: Clinical Research & Reviews | 2018 | 5 Pages |
Abstract
The increases in serum electrolytes levels may play a role in the cardiovascular protection that has been recently reported with empagliflozin and canagliflozin.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
T.D. Filippatos, V. Tsimihodimos, G. Liamis, M.S. Elisaf,